Supreme Court directs creation of permanent fund for SMA patient treatment

The Supreme Court has initiated steps to establish a dedicated permanent fund to support treatment for patients suffering from spinal muscular atrophy (SMA), a rare genetic disorder. In its directive, the court asked both the Union government and the amicus curiae to submit concrete proposals for creating this financial mechanism within a specified timeframe.

The proposed corpus would draw resources from two primary sources: corporate social responsibility (CSR) contributions from private entities and budgetary allocations from the government. This dual-funding approach aims to create a sustainable system that can provide long-term financial support for SMA patients requiring expensive therapeutic interventions.

SMA remains a significant healthcare challenge in India, as the disease requires ongoing treatment and management. The court's intervention underscores the judicial system's recognition of the financial burden placed on patients and their families while seeking to address gaps in existing healthcare support mechanisms.

The directive reflects growing judicial attention to rare disease management in India, where treatment costs often exceed the financial capacity of individual patients. By mandating the creation of a permanent corpus, the Supreme Court aims to ensure that financial constraints do not become a barrier to accessing critical medical care for this vulnerable patient population.